2024/06/04 09:00:23 | |
---|---|
Price | |
80.35 CHF | |
Difference | -0.47% (-0.38) |
ISIN | CH0432492467 |
Symbol | ALC |
Exchange | London Stock Exchange European Trade Reporting |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 40,320 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 76.34 CHF (1,000) |
Ask (Ask size) | 84.36 CHF (1,000) |
Open | 80.35 CHF |
High | 80.35 CHF |
Low | 80.35 CHF |
Close (prev. day) | 80.73 CHF |
VWAP | 79.843049 CHF |
Volume (pcs) | 10 |
Trading volume | - |
Number of trades | 1 |
Last size | - |
Related Futures | 30 |
Related Options | - |
Date | Headline | Download | |
2024/05/29 |
![]() |
Global Equity Ratings |
![]() |
2024/04/26 |
![]() |
Global Equity Ratings |
![]() |
2024/04/03 |
![]() |
Global Equity Ratings |
![]() |
2024/03/13 |
![]() |
Global Equity Ratings |
![]() |
2024/02/22 |
![]() |
Global Equity Ratings |
![]() |
2024/06/04 09:00:23 | |
---|---|
Price | |
80.35 CHF | |
Difference | -0.47% (-0.38) |
ISIN | CH0432492467 |
Symbol | ALC |
Exchange | London Stock Exchange European Trade Reporting |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 40,320 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 76.34 CHF (1,000) |
Ask (Ask size) | 84.36 CHF (1,000) |
Open | 80.35 CHF |
High | 80.35 CHF |
Low | 80.35 CHF |
Close (prev. day) | 80.73 CHF |
VWAP | 79.843049 CHF |
Volume (pcs) | 10 |
Trading volume | - |
Number of trades | 1 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +22.60% | +13.05% | +29.17% |
Perf (abs.) | +14.88 | +9.32 | +18.23 |
Beta | 0.71 | 0.89 | 1.07 |
Volatility | 24.08 | 21.85 | 26.21 |
Ø price 5 days | Ø volume 5 days (pcs.) | 80.60 CHF (511) |
Ø price 30 days | Ø volume 30 days (pcs.) | 76.76 CHF (72,560) |
Ø price 100 days | Ø volume 100 days (pcs.) | 73.03 CHF (22,374) |
Ø price 250 days | Ø volume 250 days (pcs.) | 70.77 CHF (9,970) |
YTD High | date | 83.20 CHF (2024/05/23) |
YTD Low | date | 62.36 CHF (2024/01/03) |
52 Weeks High | date | 83.20 CHF (2024/05/23) |
52 Weeks Low | date | 62.16 CHF (2023/11/17) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2019/06/28 | 22:26 | 54.15 EUR | 0.38 | 102 |
SIX Swiss Exchange | 2024/06/04 | 13:00 | 80.08 CHF | 6.12 | 732 |
NYSE | 2024/06/03 | 22:00 | 89.64 USD | 63.42 | 11,859 |
London Stock Exchange European Trade Reporting | 2024/06/04 | 09:00 | 80.35 CHF | 0.00 | 1 |
Hanover | 2019/06/28 | 08:00 | 52.91 EUR | 0.00 | 2 |
Hamburg | 2019/06/28 | 12:29 | 53.43 EUR | 0.01 | 4 |
Frankfurt | 2019/06/28 | 17:10 | 54.07 EUR | 0.06 | 23 |
Duesseldorf | 2019/06/28 | 11:10 | 53.10 EUR | 0.00 | 2 |
Berlin | 2019/06/28 | 18:47 | 54.31 EUR | 0.00 | 7 |
ALCON AG |
- - |
Royce Bedward, Chemin de Blandonnet 8 - 1214 Genf |
Telefon: +41-817-293-04-50 |
Fax: +41-817-916-26-52 |
E-mail: - |
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland. |
David J. Endicott | Chairman of Managing Board |
Ian Bell | Member of Executive Committee |
Laurent Attias | Member of Executive Committee |
Rajkumar Narayanan | Member of Executive Committee |
Sergio Duplan | Member of Executive Committee |
Sue-Jean Lin | Member of Executive Committee |
Tim Stonesifer | Member of Executive Committee |
Arthur Cummings | Member of the administrative board |
Bono Raquel Cruz | Member of the administrative board |
Dieter Spälti | Member of the administrative board |
D. Grossman | Member of the administrative board |
Ines Pöschel | Member of the administrative board |
Karen May | Member of the administrative board |
Lynn Bleil | Member of the administrative board |
Scott Maw | Member of the administrative board |
Thomas Heinrich Glanzmann | Member of the administrative board |
F. Ball | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer